481 related articles for article (PubMed ID: 27165418)
1. The current role of thiazolidinediones in diabetes management.
Rizos CV; Kei A; Elisaf MS
Arch Toxicol; 2016 Aug; 90(8):1861-81. PubMed ID: 27165418
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone is a valid alternative to rosiglitazone.
Derosa G
Am J Cardiovasc Drugs; 2011 Dec; 11(6):357-62. PubMed ID: 21950735
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus.
Defronzo RA; Mehta RJ; Schnure JJ
Hosp Pract (1995); 2013 Apr; 41(2):132-47. PubMed ID: 23680744
[TBL] [Abstract][Full Text] [Related]
4. The safety of thiazolidinediones.
Tolman KG
Expert Opin Drug Saf; 2011 May; 10(3):419-28. PubMed ID: 21366501
[TBL] [Abstract][Full Text] [Related]
5. Thiazolidinedione safety.
Kung J; Henry RR
Expert Opin Drug Saf; 2012 Jul; 11(4):565-79. PubMed ID: 22616948
[TBL] [Abstract][Full Text] [Related]
6. How safe is the use of thiazolidinediones in clinical practice?
Rizos CV; Elisaf MS; Mikhailidis DP; Liberopoulos EN
Expert Opin Drug Saf; 2009 Jan; 8(1):15-32. PubMed ID: 19236215
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: comparison with other oral antihyperglycaemic agents.
Derosa G
Drugs; 2010 Oct; 70(15):1945-61. PubMed ID: 20883052
[TBL] [Abstract][Full Text] [Related]
8. PPAR- γ agonist in treatment of diabetes: cardiovascular safety considerations.
Abbas A; Blandon J; Rude J; Elfar A; Mukherjee D
Cardiovasc Hematol Agents Med Chem; 2012 Jun; 10(2):124-34. PubMed ID: 22471957
[TBL] [Abstract][Full Text] [Related]
9. Different effects of thiazolidinediones on cardiovascular risk in patients with type 2 diabetes mellitus: pioglitazone versus rosiglitazone.
Simó R; Rodriguez A; Caveda E
Curr Drug Saf; 2010 Jul; 5(3):234-44. PubMed ID: 20210732
[TBL] [Abstract][Full Text] [Related]
10. Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
Consoli A; Formoso G
Diabetes Obes Metab; 2013 Nov; 15(11):967-77. PubMed ID: 23522285
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone: side effect and safety profile.
Shah P; Mudaliar S
Expert Opin Drug Saf; 2010 Mar; 9(2):347-54. PubMed ID: 20175701
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
Khanderia U; Pop-Busui R; Eagle KA
Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists on glycemic control, lipid profile and cardiovascular risk.
Derosa G; Maffioli P
Curr Mol Pharmacol; 2012 Jun; 5(2):272-81. PubMed ID: 22122457
[TBL] [Abstract][Full Text] [Related]
14. Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis.
Lecka-Czernik B
Curr Osteoporos Rep; 2010 Dec; 8(4):178-84. PubMed ID: 20809203
[TBL] [Abstract][Full Text] [Related]
15. Is the evidence from clinical trials for cardiovascular risk or harm for glitazones convincing?
Mannucci E; Monami M
Curr Diab Rep; 2009 Oct; 9(5):342-7. PubMed ID: 19793503
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability.
Vasudevan AR; Balasubramanyam A
Diabetes Technol Ther; 2004 Dec; 6(6):850-63. PubMed ID: 15684639
[TBL] [Abstract][Full Text] [Related]
17. The safety of rosiglitazone in the treatment of type 2 diabetes.
Singh S; Loke YK
Expert Opin Drug Saf; 2008 Sep; 7(5):579-85. PubMed ID: 18759710
[TBL] [Abstract][Full Text] [Related]
18. [Therapy with glitazones--a risk for cardiovascular disease?].
Rottlaender D; Michels G; Erdmann E; Hoppe UC
Dtsch Med Wochenschr; 2007 Dec; 132(49):2629-32. PubMed ID: 18050028
[TBL] [Abstract][Full Text] [Related]
19. [Effects of thiazolidinediones on dyslipidemia in patients with type 2 diabetes. Are all equally vasoprotective?].
Haberbosch W
Herz; 2007 Feb; 32(1):51-7. PubMed ID: 17323035
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones: the Forgotten Diabetes Medications.
Lebovitz HE
Curr Diab Rep; 2019 Nov; 19(12):151. PubMed ID: 31776781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
